Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Researchers are calling for larger, well-designed randomized controlled trials in humans to determine whether these impressive animal results translate to clinical practice
Reactive oxygen species in health and disease
RRx-001, a novel clinical-stage chemosensitizer, radiosensitizer, and immunosensitizer, inhibits glucose 6-phosphate dehydrogenase in human tumor cells
Researchers noticed that the stomach, despite being exposed to acid that would destroy most tissues, is remarkably self-repairing
Qinglu Wang, [email protected] This article was submitted to Inflammation, a section of the journal Frontiers in Immunology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
US$ 22.45
US$ 20.50
US$ 25.46
US$ 27.45
US$ 28.23
US$ 23.41
US$ 29.71
US$ 27.27
US$ 27.03
US$ 24.33
US$ 26.79
US$ 27.97
